Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells.
about
Regulation of adaptive immunity; the role of interleukin-10Theiler's virus infection: a model for multiple sclerosisAbsence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitisMechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis.The application of gene therapy in autoimmune diseases.Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response.Immune function of microglia.Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.Disease-dependent local IL-10 production ameliorates collagen induced arthritis in miceTr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading.Gene therapy in autoimmune, demyelinating disease of the central nervous system.Vectors for the treatment of autoimmune disease.Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis.Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.Gene therapy for autoimmune diseases: quo vadis?Peptide-based therapeutic vaccines for allergic and autoimmune diseases.IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAEControl of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulationTGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAESpontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis.Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitisInterleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivoAn interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.Application of cellular gene therapy for rheumatoid arthritisAntigen-specific immunotherapy for autoimmune diseases.Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis.TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10.The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes.Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis.Gene therapy in the treatment of autoimmune diseases.Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis.Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis.Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors.Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients.
P2860
Q21131215-95BEE982-0A2D-4019-868A-681326EF7787Q24629115-907F5D21-66EA-45C5-A7FE-0240700EFCEBQ28755978-A8765532-DF98-45A5-A1FF-7C34839AA256Q33713307-A10193A1-B1D2-4127-8E7F-EF4FDFA3A21FQ33840979-A7C92924-DBB0-4D76-B8B6-E1B4934A2C4EQ33867180-7D413FE6-4791-47FF-AC93-54AD7985761DQ34094707-9940A90E-A0D9-4FA1-9D53-F28A6BB80FC3Q34333361-CB50BFC7-DA8A-4434-A323-76E058F5E89BQ34482730-E8E1D3DC-4301-4618-8561-D69A1BF70A2DQ34795755-5155F85E-79E5-4401-ABCC-C0703A9794D5Q35122159-D2A448F3-B234-4DA4-A9CA-CFE25446E498Q35122178-55F501A2-A491-4DAE-A222-BAD5E8ABDB89Q35159951-BAB74722-DB60-4062-99E5-D615FCAA2194Q35861182-487FE41E-2417-46A8-B410-659B52E029A1Q35906093-1B8B431F-F2A5-48D1-B2E3-9B09D20EC7E2Q36090197-459ADD69-D9AB-4E5D-ACDD-F18F494A88ACQ36103132-6CB9B900-102E-4272-B412-5E09FFD5EA72Q36226146-89E4BF22-6494-4949-98E6-03C7EE7BC5D7Q36340416-388B678C-5C78-416E-A89E-4641379FB8D4Q36368003-95AA9F10-632B-4566-8D7A-633966AC91BEQ36368128-D2D8317B-1CF5-410E-A598-55A0054E3C1CQ36368628-BE9D47CD-ED10-4EBA-89DC-BABB2A887579Q36400127-284DC93C-2490-4B88-9759-E3AFC096A6A0Q36400329-D7920758-D4E3-4BA1-9AF4-A081D66F6213Q36449562-B628A222-3BB7-4788-A546-3508F4B4282DQ36525918-CA592CEE-61C0-4DC7-8C01-35A63701F5E2Q36622653-E8B6F86C-C6D5-4D40-90F4-CC9C51810271Q36739772-1F8FE1F1-8E34-4B11-8EBC-608002A37B9EQ36802175-FE8BA1B3-1FA4-47ED-9681-0539B2FD62F1Q37244144-0F32A186-D71D-43DA-B37C-CD55D627590AQ37621601-8B87E6ED-B94B-4908-8A0A-5F3AB70483D4Q38104409-73DB9960-EC67-4815-B1F7-5F9B686BC14CQ39946625-5A32556C-2A8E-4AF5-866A-E0830706323EQ39946646-9675F226-07C6-4570-A300-03E7865C2BA5Q40431834-5BF7B976-787E-47CD-A127-8B19E374DF2CQ40445781-335C427C-DBD6-449F-9D94-3BAAF9D3D56DQ41745135-2BA7D3FA-E1C2-4B0E-A387-593B19E81622Q44529066-FF0A8134-1ED0-4298-896A-5909AF485C18Q45410674-D817C4C4-3DEB-44CE-AD93-D6DA021BFD73Q45862110-27640A03-359B-4ADB-9ABB-AE45F0A41254
P2860
Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Treatment of experimental auto ...... cally modified memory T cells.
@ast
Treatment of experimental auto ...... cally modified memory T cells.
@en
type
label
Treatment of experimental auto ...... cally modified memory T cells.
@ast
Treatment of experimental auto ...... cally modified memory T cells.
@en
prefLabel
Treatment of experimental auto ...... cally modified memory T cells.
@ast
Treatment of experimental auto ...... cally modified memory T cells.
@en
P2093
P2860
P356
P1476
Treatment of experimental auto ...... cally modified memory T cells.
@en
P2093
P2860
P304
P356
10.1084/JEM.186.1.159
P407
P577
1997-07-01T00:00:00Z